Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective

Y Yang, S Li, Y Wang, Y Zhao, Q Li - Signal transduction and targeted …, 2022 - nature.com
Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …

Friend or foe? The elusive role of hepatic stellate cells in liver cancer

B Cogliati, CN Yashaswini, S Wang, D Sia… - Nature Reviews …, 2023 - nature.com
Liver fibrosis is a substantial risk factor for the development and progression of liver cancer,
which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma …

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory …

GQ Zhu, Z Tang, R Huang, WF Qu, Y Fang, R Yang… - Cell discovery, 2023 - nature.com
Hepatocellular carcinoma (HCC) is an immunotherapy-resistant malignancy characterized
by high cellular heterogeneity. The diversity of cell types and the interplay between tumor …

New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects

M Huang, Y Lin, C Wang, L Deng, M Chen… - Drug resistance …, 2022 - Elsevier
Angiogenesis is a hallmark of cancer and is required for tumor growth and progression.
Antiangiogenic therapy has been revolutionarily develo** and was approved for the …

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib

JW Eun, JH Yoon, HR Ahn, S Kim, YB Kim… - Cancer …, 2023 - Wiley Online Library
Abstract Background Cancer‐associated fibroblasts (CAFs) play an important role in the
induction of chemo‐resistance. This study aimed to clarify the mechanism underlying CAF …

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments

Y Zhang, Q Hu, Y Pei, H Luo, Z Wang, X Xu… - Nature …, 2024 - nature.com
Cancer models play critical roles in basic cancer research and precision medicine.
However, current in vitro cancer models are limited by their inability to mimic the three …

Cancer organoid co-culture model system: Novel approach to guide precision medicine

J Yuan, X Li, S Yu - Frontiers in Immunology, 2023 - frontiersin.org
Three-dimensional cancer organoids derived from self-organizing cancer stems are ex vivo
miniatures of tumors that faithfully recapitulate their structure, distinctive cancer features, and …

Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology

L Thorel, M Perréard, R Florent, J Divoux… - … & Molecular Medicine, 2024 - nature.com
Over the past decade, the emergence of patient-derived tumor organoids (PDTOs) has
broadened the repertoire of preclinical models and progressively revolutionized three …

Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment

MR Haque, CR Wessel, DD Leary, C Wang… - Microsystems & …, 2022 - nature.com
The patient population suffering from pancreatic ductal adenocarcinoma (PDAC) presents,
as a whole, with a high degree of molecular tumor heterogeneity. The heterogeneity of …

Role of patient-derived models of cancer in translational oncology

KF Idrisova, HU Simon, MO Gomzikova - Cancers, 2022 - mdpi.com
Simple Summary It was found that long-established tumor-derived cell lines do not
adequately reproduce drug sensitivity and behavior of a real human cancers. Therefore …